Taken gather, these findings indicated that HDAC inhibitors inhibited the growth of HCC cells primarily by reducing the population of proliferating cells and inducing cell cycle arrest in the G0/G1 phase, with a significant decrease in the S-phase population. This evidence concerns the gene HDAC9 and hepatocellular carcinoma.